These mutations result in reduced BACH2 expression and transcriptional repression of BLIMP in patient lymphoblastoid cells, reduced memory B cells, and systemic lupus erythematosus (SLE) symptoms [21,22]. The gene discussed is BACH2; the disease is systemic lupus erythematosus.